Raymond James & Associates Virios Therapeutics, Inc. Call Options Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VIRI
# of Institutions
16Shares Held
520KCall Options Held
0Put Options Held
0-
Jane Street Group, LLC New York, NY28KShares$124,4620.0% of portfolio
-
Morgan Stanley New York, NY15.2KShares$67,4920.0% of portfolio
-
Urban Wealth Management, LLC2.46KShares$10,9000.03% of portfolio
-
Cutler Group LP2.3KShares$10,2120.0% of portfolio
-
Black Rock Inc. New York, NY755Shares$3,3520.0% of portfolio
About Virios Therapeutics, Inc.
- Ticker VIRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,330,400
- Market Cap $81.4M
- Description
- Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...